Tirzepatide Dosage Chart: Full Titration Schedule Explained

TL;DR

• Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight loss) starts at 2.5 mg once weekly for all patients. This starting dose is not a maintenance dose.

• After 4 weeks at 2.5 mg, dose increases to 5 mg weekly. From there, it can be increased by 2.5 mg every 4 weeks based on tolerability and treatment response.

• Available strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The maximum dose is 15 mg per week.

• Approved maintenance doses are 5 mg, 10 mg, or 15 mg. The 2.5 mg, 7.5 mg, and 12.5 mg doses are transitional steps, not intended as long-term maintenance.

• The full titration from 2.5 mg to 15 mg takes a minimum of 20 weeks if increasing every 4 weeks without pausing. Most people take longer based on side effect management.

How Tirzepatide Dosing Works

Tirzepatide is a once weekly subcutaneous injection that activates two gut hormone receptors: GLP-1 (glucagon like peptide 1) and GIP (glucose dependent insulinotropic polypeptide). This dual mechanism is what sets it apart from semaglutide-based medications like Ozempic and Wegovy, which only target GLP-1.

Both Mounjaro and Zepbound contain exact same tirzepatide molecule at same strengths. The dosing protocol is identical for both. The only difference is approved indication: Mounjaro for blood sugar control in type 2 diabetes, Zepbound for chronic weight management and obstructive sleep apnea in adults with obesity or overweight with at least one weight-related condition.

The FDA prescribing label for Zepbound outlines complete dosing schedule and confirms that titration protocol is same across all approved indications.

The Full Titration Schedule

Here is standard FDA-approved dosing escalation for tirzepatide. Each step lasts a minimum of 4 weeks before moving to next dose.

• Weeks 1 through 4: 2.5 mg once weekly (starting dose only, not a maintenance dose)

• Weeks 5 through 8: 5 mg once weekly (first approved maintenance dose)

• Weeks 9 through 12: 7.5 mg once weekly (transitional dose)

• Weeks 13 through 16: 10 mg once weekly (second approved maintenance dose)

• Weeks 17 through 20: 12.5 mg once weekly (transitional dose)

• Week 21 onward: 15 mg once weekly (maximum approved maintenance dose)

Not everyone follows this exact timeline. Your provider may hold you at a particular dose for longer than 4 weeks if you are tolerating it well and seeing adequate results, or if side effects need time to settle before moving up. There is no requirement to reach 15 mg. Many people find their effective maintenance dose at 5 mg or 10 mg and stay there.

Why Does Titration Start So Low?

The 2.5 mg starting dose is not meant to produce significant weight loss or blood sugar reduction on its own. Its purpose is to give your body time to adjust to tirzepatide's effects on digestion, appetite, and blood sugar regulation.

Tirzepatide slows gastric emptying, which means food moves through your stomach more slowly. This is a key part of how drug reduces appetite and promotes fullness, but it also causes most common side effects: nausea, diarrhea, vomiting, constipation, and abdominal discomfort.

Starting low and increasing gradually reduces intensity of these GI side effects. Clinical trials showed that most GI symptoms peak during dose escalation periods and then improve once your body adjusts to new dose. Discontinuation rates due to GI side effects ranged from about 4% to 7% across all dose groups in SURMOUNT trials, which is relatively low given level of nausea reported.

If GI symptoms are giving you trouble at any dose, this article on whether tirzepatide causes diarrhea breaks down what to expect at each stage and how to manage it.

Which Doses Are Maintenance Doses?

This distinction matters. Not all six available strengths are intended for long-term use.

The approved maintenance doses for Zepbound (weight loss) are 5 mg, 10 mg, and 15 mg weekly. For Mounjaro (type 2 diabetes), same three doses are considered maintenance, with choice based on glycemic control and tolerability.

The 2.5 mg dose is for initiation only. The 7.5 mg and 12.5 mg doses are transitional steps designed to ease jump between maintenance levels. You pass through them on way up, but they are not intended as stopping points.

That said, your provider has flexibility to keep you at any dose if it is working well. If 7.5 mg is producing good results with manageable side effects, staying there is a clinical decision your provider can make. The labels describe standard protocol, but real-world prescribing often adapts to individual response.

How Much Weight Can You Expect at Each Dose?

The SURMOUNT-1 trial measured weight loss at each maintenance dose over 72 weeks. Here is what data showed for people using Zepbound for weight management.

At 5 mg weekly, participants lost an average of about 15% of their body weight, roughly 34 pounds. At 10 mg weekly, average was about 19.5%, roughly 44 pounds. At 15 mg weekly, average reached about 20.9%, roughly 48 pounds. The placebo group lost about 3.1%, roughly 7 pounds.

The biggest jump in efficacy happened between 5 mg and 10 mg. Going from 10 mg to 15 mg added another 1 to 2 percentage points on average. For some people, that additional benefit is worth higher dose. For others, side effect tradeoff is not justified, and 10 mg provides a strong result with better tolerability.

What Happens After You Reach Your Goal?

This is one of most important questions in tirzepatide treatment. Once you have reached your target weight or blood sugar goal, you still need to stay on a maintenance dose. The SURMOUNT-4 trial showed that people who stopped tirzepatide after reaching their goals regained a significant portion of weight, while those who continued treatment maintained their results.

Your maintenance dose does not have to be highest dose you used during active weight loss. Some providers taper patients down to a lower maintenance dose (such as 5 mg or 10 mg) once initial weight loss phase is complete. This approach can reduce long-term side effects and lower medication costs while preserving majority of benefit.

For a deeper look at how maintenance dosing works after you have reached your weight loss target, this guide on tirzepatide maintenance dose after weight loss covers evidence and common strategies.

Practical Tips for Titration Period

A few things can make dose escalation process smoother. Inject on same day each week. You can choose any day, but consistency helps maintain steady drug levels. Inject in abdomen, thigh, or upper arm, and rotate sites with each injection. If you miss a dose, take it within 4 days (96 hours). If more than 4 days have passed, skip it and resume on your next scheduled day.

Eating smaller, more frequent meals during dose increases can help manage nausea. Avoid high-fat and greasy foods, which tend to worsen GI symptoms when gastric emptying is slowed. Stay well hydrated, especially if you experience diarrhea or vomiting.

If you take oral contraceptives, be aware that tirzepatide can reduce their absorption due to delayed gastric emptying. The FDA recommends using a backup method of contraception for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.

Conclusion

Tirzepatide follows a clear, stepwise titration starting at 2.5 mg and increasing by 2.5 mg every 4 weeks up to a maximum of 15 mg. The goal is to find lowest effective maintenance dose that balances results with tolerability. Not everyone needs to reach 15 mg, and data supports strong outcomes at 5 mg and 10 mg as well. Work with your provider to find dose that fits your body, your goals, and your comfort level.